glp-1 + nad+ Cardiovascular Protection with a Long-Acting Receptor Agonist Liraglutide: An Experimental Update GLP-1 Boost & NAD+ Vitality

A new preclinical study at Northwestern Universitys Feinberg School of Medicine found that disrupting complex I function in mouse dopaminergic neurons led to progressive PD-related motor deficits, with loss of dopamine release in the substantia nigra being critical for motor deficits (40)

Potential additional benefits are actions to promote -cell survival by slowing apoptosis or to promote -cell regeneration by stimulating -cell proliferation

Patients with significant dietary restrictions or ongoing nutritional concerns may benefit from referral to a registered dietitian

Direct longitudinal human studies evaluating tissue-specific NAD dynamics during GLP-1RA therapy remain limited

Ordering of labs by your medical provider is included, however the cost of labs, medications, and imaging are not included with the $75 self pay visit charge or membership fees, as they are billed at the local lab center partner, pharmacy, or imaging center

Tapering protocols that reduce the shock of discontinuation